Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
First ECHO Pitch 2019 competition a huge success, unanimous winner takes $250,000 in startup funding
At ECHO PITCH 2019, one startup earned $250K in funding
Ted Rogers Centre investigator’s medical implant technology set to go global
Paul Santerre’s latest commercialization success
ECHO program supports efforts to prevent ischemia-reperfusion injury in the heart
A novel peptide may solve this phenomenon
Our 2019 Innovation Fund awards: 3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
Three bold projects target special challenges in HF
World-first technology to clear the heart of dangerous protein deposits
‘Desperate need for therapies for AL amyloid cardiomyopathy’
Ted Rogers Centre director leads new landmark diabetes paper
PIONEER 6 finds novel GLP-1 RA is safe for the heart
B-cell deficiency found to lower blood pressure
B-cell deficiency found to lower blood pressure
Trans-Atlantic partnership seeks answers for cyanotic heart disease
New genetic insights and pipelines for discovery
Confronting one of the world’s greatest health challenges
Collaborative Ted Rogers Centre has taken new aim at heart failure
The new heart risk factor we must all begin to consider
How clonal hematopoiesis may drive heart disease